Guardant Health Inc (NAS:GH)
$ 29.54 0 (0%) Market Cap: 3.61 Bil Enterprise Value: 3.83 Bil PE Ratio: 0 PB Ratio: 52.66 GF Score: 70/100

Guardant Health Inc at JPMorgan Healthcare Conference Transcript

Jan 08, 2024 / 11:45PM GMT
Release Date Price: $26.91 (+4.38%)
Rachel Vatnsdal JPMorgan;Analyst

Perfect. Good afternoon, everyone. This is Rachel Vatnsdal with the life science tools and diagnostics team at JPMorgan. Thank you so much for joining us today for Guardant Health's presentation.

So as you've seen with most of these, it's going to be 20 minutes roughly of presentation, followed by 20 minutes of Q&A. (Conference Instructions)

And with that, I will pass it off to Helmy. Thank you.

Helmy Eltoukhy Guardant Health
Inc. - Chairman & Co-CEO

Thank you, Rachel, and it's great to be here. So thank you, everyone, for joining us today. Here's our forward-looking statement.

So we founded Guardant Health 11 years ago with the bold mission of giving us, our families, friends, and loved ones all more time free from cancer -- disease that we believe could be ultimately conquered using vast amounts of data as our weapon.

And in those 11 years, we have delivered on that promise. We now have a robust suite of precision oncology products addressing both late and early-stage

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot